Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
10 mg Prednisone[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 44
25 mg Prednisone[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 44
35-Aminosalicylic acid(5-ASA) and/or Prednisone[3] Aminosalicylic acid,
Mesalazine,
Prednisone		[3] D00162 ,
D00377 ,
D00473 (Name: Prednisone)		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 97
4Adalimumab, plus prednisone[2] Adalimumab,
Prednisone		[2] D00473 (Name: Prednisone),
D02597 		[2] NR3C1,
TNF 💬		[68] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46
5Administration of Methylprednisolone + Prednisone + Mycophenolate mofetil[4] Methylprednisolone,
Mycophenolate mofetil,
Mycophenolic acid,
Prednisone		[11] D00407 ,
D00473 (Name: Prednisone),
D00751 ,
D00752 ,
D00979 ,
D05000 ,
D05001 ,
D05002 ,
D05094 ,
D05095 ,
D05096 		[3] IMPDH1,
IMPDH2,
NR3C1 💬		[4] Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism 💬[1] 49
6Azathioprine/prednisone[2] Azathioprine,
Prednisone		[3] D00238 ,
D00473 (Name: Prednisone),
D03033 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 85
7Behavioral: Duchenne Muscular Dystrophy group with Prednisone/Predisolone[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 113
8Capsule di prednisone[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
9Chinese Herb Prescription Granule plus prednisone[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 66
10Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)[6] Acetate,
Cortisone acetate,
Dexamethasone,
Hydrocortisone,
Prednisolone,
Prednisone		[20] D00088 ,
D00292 ,
D00472 ,
D00473 (Name: Prednisone),
D00973 ,
D00975 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D01998 ,
D02156 ,
D02174 ,
D02591 ,
D02592 ,
D03301 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
11Corticosteroids (prednisone or prednisolone)[2] Prednisolone,
Prednisone		[9] D00472 ,
D00473 (Name: Prednisone),
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 49
12Cyclophosphamide, Azathioprine,prednisone,methylprednisolone[4] Azathioprine,
Cyclophosphamide,
Methylprednisolone,
Prednisone		[11] D00238 ,
D00287 ,
D00407 ,
D00473 (Name: Prednisone),
D00751 ,
D00979 ,
D03033 ,
D05000 ,
D05001 ,
D05002 ,
D07760 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 42, 43, 45
13Cyclophosphamide-prednisone-azathioprine[3] Azathioprine,
Cyclophosphamide,
Prednisone		[5] D00238 ,
D00287 ,
D00473 (Name: Prednisone),
D03033 ,
D07760 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 49
14DECORTIN (PREDNISONA) 5 MG COMPRIMIDOS[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
15Glucocorticoid (prednisone or prednisolone)[2] Prednisolone,
Prednisone		[9] D00472 ,
D00473 (Name: Prednisone),
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 84
16Granulocyte-colony stimulating factor (G-CSF) and prednisone[2] Filgrastim,
Prednisone		[2] D00473 (Name: Prednisone),
D03235 		[2] CSF3R,
NR3C1 💬		[6] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pathways in cancer 💬[1] 13
17Hormone (prednisone)[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 66
18Hydroxychloroquine + low-dose prednisone[2] Hydroxychloroquine,
Prednisone		[2] D00473 (Name: Prednisone),
D08050 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 84
19Hydroxychloroquine + Prednisone[2] Hydroxychloroquine,
Prednisone		[2] D00473 (Name: Prednisone),
D08050 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 84
20IR Prednisone[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
21Leflunomide 20 mg+prednisone 0.5mg/kg/d[2] Leflunomide,
Prednisone		[2] D00473 (Name: Prednisone),
D00749 		[2] DHODH,
NR3C1 💬		[4] Biosynthesis of cofactors, Metabolic pathways, Neuroactive ligand-receptor interaction, Pyrimidine metabolism 💬[1] 66
22Methylprednisolone (MP) or prednisone (pred)[2] Methylprednisolone,
Prednisone		[7] D00407 ,
D00473 (Name: Prednisone),
D00751 ,
D00979 ,
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 66
23MR Prednisone[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
24Mycophenolate mofetil plus lower dose of Prednisone[3] Mycophenolate mofetil,
Mycophenolic acid,
Prednisone		[5] D00473 (Name: Prednisone),
D00752 ,
D05094 ,
D05095 ,
D05096 		[3] IMPDH1,
IMPDH2,
NR3C1 💬		[4] Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism 💬[1] 66
25Oral prednisone[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 251
26Oral Prednisone 5mg[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 49
27Other: prednisone[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
28Over encapsulated prednisone[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
29Prednisolone/Prednisone[2] Prednisolone,
Prednisone		[9] D00472 ,
D00473 (Name: Prednisone),
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 49
30Prednison----[3] 46, 84, 113
31Prednison 10 mg GALEN----[1] 35
32Prednison 5 mg GALEN----[1] 35
33PREDNISON 5, 20 Léciva por. tablet nob----[1] 50
34Prednison 5, 20 Léciva por. tablet nob.----[1] 50
35Prednison 50 mg GALEN----[1] 35
36Prednison acis® 20 mg----[2] 43, 44
37Prednison acis® 5 mg----[2] 43, 44
38Prednison acis¿ 20 mg----[2] 43, 44
39Prednison acis¿ 5 mg----[2] 43, 44
40Prednison20 mg GALEN----[1] 35
41Prednisona[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 46, 49, 222
42Prednisone[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[48] 2, 6, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 127, 162, 164, 205, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331
43Prednisone (and methylprednisolone)[2] Methylprednisolone,
Prednisone		[7] D00407 ,
D00473 (Name: Prednisone),
D00751 ,
D00979 ,
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 43
44Prednisone + Inhibace/Cozaar[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 66
45Prednisone - Azathioprine[2] Azathioprine,
Prednisone		[3] D00238 ,
D00473 (Name: Prednisone),
D03033 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 11
46Prednisone 0,5 mg/kg orally on alternate days[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 222
47Prednisone 1 mg[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
48Prednisone 15 mg[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
49Prednisone 2 mg[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
50Prednisone 3 mg[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
51Prednisone 4 mg[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
52Prednisone 5 mg[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 46, 66
53Prednisone 5 mg tablets[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 113
54Prednisone 7.5 mg[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
55Prednisone Acetate[3] Acetate,
Prednisone,
Prednisone acetate		[2] D00473 (Name: Prednisone),
D08416 (Name: Prednisone acetate)		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[4] 40, 46, 49, 224
56Prednisone Acetate Tablets[3] Acetate,
Prednisone,
Prednisone acetate		[2] D00473 (Name: Prednisone),
D08416 (Name: Prednisone acetate)		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 224
57Prednisone alone[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 11, 66
58Prednisone and Belimumab[2] Belimumab,
Prednisone		[2] D00473 (Name: Prednisone),
D03068 		[2] NR3C1,
TNFSF13B 💬		[5] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Rheumatoid arthritis 💬[1] 300
59Prednisone and cyclophosphamide[2] Cyclophosphamide,
Prednisone		[3] D00287 ,
D00473 (Name: Prednisone),
D07760 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 66
60Prednisone and Mycophenolate mofetil[3] Mycophenolate mofetil,
Mycophenolic acid,
Prednisone		[5] D00473 (Name: Prednisone),
D00752 ,
D05094 ,
D05095 ,
D05096 		[3] IMPDH1,
IMPDH2,
NR3C1 💬		[4] Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism 💬[1] 300
61Prednisone and ustekinumab treatment[2] Prednisone,
Ustekinumab		[2] D00473 (Name: Prednisone),
D09214 		[4] IL12A,
IL12B,
IL23A,
NR3C1 💬		[29] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Neuroactive ligand-receptor interaction, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 41
62PREDNISONE ARROW 20mg[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 66
63PREDNISONE ARROW 5 mg[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 66
64Prednisone Capsule[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
65Prednisone Capsules[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
66Prednisone discontinuation[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 49
67PREDNISONE DOC GENERICI - 5 MG COMPRESSE 30 COMPRESSE IN BLISTER PVC-PVDC/ALU[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 300
68Prednisone in full dose[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 66
69Prednisone or Prednisolone[2] Prednisolone,
Prednisone		[9] D00472 ,
D00473 (Name: Prednisone),
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 66, 84
70Prednisone plus cyclophosphamide[2] Cyclophosphamide,
Prednisone		[3] D00287 ,
D00473 (Name: Prednisone),
D07760 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 66
71Prednisone plus exercise[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 113
72PredniSONE Tablets USP, 1 mg[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 41, 46
73PredniSONE Tablets USP, 10 mg[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
74PredniSONE Tablets USP, 1mg[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
75PredniSONE Tablets USP, 2.5 mg[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
76PredniSONE Tablets USP, 2.5mg[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
77PredniSONE Tablets USP, 20mg[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
78PredniSONE Tablets USP, 5 mg[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 41, 46
79PredniSONE Tablets USP, 5mg[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
80PredniSONE Tablets, USP[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 41, 43, 44
81Prednisone therapy and pharmacokinetic[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
82Prednisone treatment[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
83Prednisone with daily edasalonexent[2] Edasalonexent,
Prednisone		[2] D00473 (Name: Prednisone),
D12181 		[2] NR3C1,
RELA 💬		[77] AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, Apoptosis, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, Cocaine addiction, Coronavirus disease - COVID-19, Cytosolic DNA-sensing pathway, Diabetic cardiomyopathy, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Longevity regulating pathway, MAPK signaling pathway, Measles, Mitophagy - animal, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neuroactive ligand-receptor interaction, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prolactin signaling pathway, Prostate cancer, RIG-I-like receptor signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway 💬[1] 113
84Prednisone, ciclosporin and mycophenolate mofetil[4] Cyclosporine,
Mycophenolate mofetil,
Mycophenolic acid,
Prednisone		[6] D00184 ,
D00473 (Name: Prednisone),
D00752 ,
D05094 ,
D05095 ,
D05096 		[8] IMPDH1,
IMPDH2,
NR3C1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		[37] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 222
85Prednisone, cyclophosphamide[2] Cyclophosphamide,
Prednisone		[3] D00287 ,
D00473 (Name: Prednisone),
D07760 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 40
86Prednisone, FK506, MMF[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 222
87Prednisone, low dose rituximab[2] Prednisone,
Rituximab		[2] D00473 (Name: Prednisone),
D02994 		[2] MS4A1,
NR3C1 💬		[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬[1] 61
88Prednisone, methylprednisolone,cyclophosphamides[2] Methylprednisolone,
Prednisone		[7] D00407 ,
D00473 (Name: Prednisone),
D00751 ,
D00979 ,
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 42, 43, 45
89Prednisone/Prednisolone[2] Prednisolone,
Prednisone		[9] D00472 ,
D00473 (Name: Prednisone),
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 35
90Pyridostigmine, Prednisone, Tacrolimus[3] Prednisone,
Pyridostigmine,
Tacrolimus		[4] D00107 ,
D00473 (Name: Prednisone),
D00487 ,
D08556 		[7] ACHE,
NR3C1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		[36] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Cholinergic synapse, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Glycerophospholipid metabolism, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 11
91RAYOS (delayed-release prednisone)[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
92Sotatercept with prednisone boost[2] Prednisone,
Sotatercept		[2] D00473 (Name: Prednisone),
D09670 		[2] ACVR2A,
NR3C1 💬		[5] Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Neuroactive ligand-receptor interaction, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬[1] 284
93Tacrolimus combined with prednisone[2] Prednisone,
Tacrolimus		[3] D00107 ,
D00473 (Name: Prednisone),
D08556 		[6] NR3C1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		[34] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 222
94Thalidomide, cyclophosphamide and prednisone[3] Cyclophosphamide,
Prednisone,
Thalidomide		[4] D00287 ,
D00473 (Name: Prednisone),
D00754 ,
D07760 		[2] NR3C1,
TNF 💬		[68] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 331
95Thymectomy plus prednisone[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 11
96Treatment systemic therapy (prednisone)[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 162
97Treatment with systemic therapy (prednisone)[1] Prednisone[1] D00473 (Name: Prednisone)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 162
98Vinblastine, vincristine, prednisone, daunorubicin[4] Daunorubicin,
Prednisone,
Vinblastine,
Vincristine		[7] D00473 (Name: Prednisone),
D01068 ,
D01264 ,
D02197 ,
D07776 ,
D08675 ,
D08679 		[12] NR3C1,
TOP2A,
TOP2B,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬		[12] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Platinum drug resistance, Prion disease, Salmonella infection 💬[1] 65